Clinical significance of cell differentiation in hepatocellular carcinoma

被引:0
|
作者
Ker, CG
Chen, HY
Chen, KS
Jeng, IJ
Yang, MY
Juan, CC
Chen, PH
Lo, HY
Chai, IC
Shih, DS
Sheen, II
机构
[1] Yuans Gen Hosp, Inst Hepatogastroenterol, Kaohsiung 80211, Taiwan
[2] Yuans Gen Hosp, Inst Hepatogastroenterol, Div Hepatol, Kaohsiung 80211, Taiwan
[3] Yuans Gen Hosp, Dept Pathol, Inst Hepatogastroenterol, Kaohsiung 80211, Taiwan
关键词
cell differentiation; liver cancer; cancer recurrence;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Hepatocellular carcinoma is commonly found in Asian countries and prognosis still remains unsatisfactory due to recurrence after surgical tumor resection. Methodolology: We try to demonstrate the recurrence and survival time in 99 surgical patients grading by tumor cellular differentiation from surgical specimen. Results: The rates of well, moderate, and poor differentiation were encountered in 21 cases (21.2%), 61 cases (61.6%) and 17 cases (17.7%), respectively. Small tumor (<3cm) was found in only one (5.9%) in the poor differentiation group and 38.1% and 37.7% in the well and moderate differentiation groups. Capsular invasion was found in 13 (61.9%), 39 (63.9%) and 7 (41.1%) in the well, moderate and poor differentiation group, respectively. We found 41.9% (18/43) and 22.4% (13/58) to be tumor free in capsule invasion (-) and (+) after a period of 18.1 and 29.9 months, respectively. However, the recurrent time was 10.6 and 11.3 months, respectively with no significant difference (P>0.05). Vascular invasion was more frequent in the poor differentiation group (76.5%) than the well (23.8%) and moderate (60.7%) differentiation groups (P<0.05). We found 23.5% (4/17) and 35% (21/60) to be tumor free but the recurrence time was 6.5 and 14.1 months for the vascular invasion (-) and (+), respectively. The residual median survival times were 6.5 and 14 months after recurrence, respectively. The tumor recurrence rates were 52.7% (11/21), 52.4% (32/61), and 35.5% (6/17) and recurrence times were 11. 7, 11.9, and 4.5 months for the well, mode. rate and poor differentiation group respectively totally. The recurrence time of young age group (<39 years old) was shorter than the others and there was no patient of well differentiation less than 40,years old. The recurrence time was shorter in the poor differentiation group but there was no significant difference according to age group. The median survival times were 22.2, 22.9, and 9.5 months for each group, respectively. Conclusions: Differentiation of hepatocellular carcinoma cell had a clinical significance and was found to be positively correlated with the invasive proclivity. The median survival time was longer in both the well and moderate differentiation group, but not in the poor differentiation group. The clinical data revealed that the extended operations performed upon the patients with poor differentiation effected the recurrence time but not the survival time.
引用
收藏
页码:475 / 479
页数:5
相关论文
共 50 条
  • [1] Biliary differentiation and its clinical significance in hepatocellular carcinoma.
    Park, YN
    Yoon, DS
    Chi, HS
    Park, CI
    HEPATOLOGY, 1998, 28 (04) : 736A - 736A
  • [2] Clinical significance of cell cycle inhibitors in hepatocellular carcinoma
    Matsuda, Yasunobu
    Wakai, Toshifumi
    Kubota, Masayuki
    Takamura, Masaaki
    Yamagiwa, Satoshi
    Aoyagi, Yutaka
    Osawa, Mami
    Fujimaki, Shun
    Sanpei, Ayumi
    Genda, Takuya
    Ichida, Takafumi
    MEDICAL MOLECULAR MORPHOLOGY, 2013, 46 (04) : 185 - 192
  • [3] Clinical significance of cell cycle inhibitors in hepatocellular carcinoma
    Yasunobu Matsuda
    Toshifumi Wakai
    Masayuki Kubota
    Masaaki Takamura
    Satoshi Yamagiwa
    Yutaka Aoyagi
    Mami Osawa
    Shun Fujimaki
    Ayumi Sanpei
    Takuya Genda
    Takafumi Ichida
    Medical Molecular Morphology, 2013, 46 : 185 - 192
  • [4] Clinical significance of APOB inactivation in hepatocellular carcinoma
    Gena Lee
    Yun Seong Jeong
    Do Won Kim
    Min Jun Kwak
    Jiwon Koh
    Eun Wook Joo
    Ju-Seog Lee
    Susie Kah
    Yeong-Eun Sim
    Sun Young Yim
    Experimental & Molecular Medicine, 2018, 50 : 1 - 12
  • [5] Clinical significance of RNA methylation in hepatocellular carcinoma
    Bao, Qiongling
    Zeng, Yifan
    Lou, Qizhuo
    Feng, Xuewen
    Jiang, Shuwen
    Lu, Juan
    Ruan, Bing
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [6] Clinical significance and implication of neoangiogenesis in hepatocellular carcinoma
    Park, James O.
    Yeh, Matthew M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (05) : 792 - 793
  • [7] Clinical significance of APOB inactivation in hepatocellular carcinoma
    Lee, Gena
    Kwak, Min Jun
    Kim, Do Won
    Koh, Jiwon
    Joo, Eun Wook
    Kah, Susie
    Sim, Yeong-Eun
    Yim, Sun Young
    Lee, Ju-Seog
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Clinical significance of RNA methylation in hepatocellular carcinoma
    Qiongling Bao
    Yifan Zeng
    Qizhuo Lou
    Xuewen Feng
    Shuwen Jiang
    Juan Lu
    Bing Ruan
    Cell Communication and Signaling, 22
  • [9] Clinical significance of APOB inactivation in hepatocellular carcinoma
    Lee, Gena
    Jeong, Yun Seong
    Kim, Do Won
    Kwak, Min Jun
    Koh, Jiwon
    Joo, Eun Wook
    Lee, Ju-Seog
    Kah, Susie
    Sim, Yeong-Eun
    Yim, Sun Young
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 : 1 - 12
  • [10] Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
    Sung, Jong Jin
    Noh, Sang Jae
    Bae, Jun Sang
    Park, Ho Sung
    Jang, Kyu Yun
    Chung, Myoung Ja
    Moon, Woo Sung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2016, 50 (01) : 52 - 57